Poster Title

P-29 Assessing Boronic Acid Substituted Arylidene-Thiobarbiturates as Bifunctional Nanoparticles

Presenter Information

Dillon Zimmerman, Andrews University

Abstract

We wish to assess the efficacy of boronic acid containing arylidene-thiobarbiturates as bifunctional molecule linkers between metal nanoparticles and metal oxides. Organic synthesis of arylidene-thiobarbiturates will occur by Knoevenagel condensation of thiobarbituric acid with formylphenylboronic acids. The chemical literature shows thio functionalities bind to metal nanoparticles while boronic acids bind to metal oxides. However, we have not seen boronic acid substituted arylidene thiobarbiturates synthesized or studied as bifunctional nanoparticle linkers. QCM, among other techniques, will assess the adherence of the bifunctional linkers to both the metal nanoparticles and metal oxides. Our group will synthesize naked silver nanoparticles and arylidene-thiobarbiturates.

Acknowledgments

Dr. Getahun Merga & Dr. Desmond Murray

Location

Buller Hall

Start Date

2-26-2016 2:30 PM

End Date

2-26-2016 4:00 PM

This document is currently not available here.

COinS
 
Feb 26th, 2:30 PM Feb 26th, 4:00 PM

P-29 Assessing Boronic Acid Substituted Arylidene-Thiobarbiturates as Bifunctional Nanoparticles

Buller Hall

We wish to assess the efficacy of boronic acid containing arylidene-thiobarbiturates as bifunctional molecule linkers between metal nanoparticles and metal oxides. Organic synthesis of arylidene-thiobarbiturates will occur by Knoevenagel condensation of thiobarbituric acid with formylphenylboronic acids. The chemical literature shows thio functionalities bind to metal nanoparticles while boronic acids bind to metal oxides. However, we have not seen boronic acid substituted arylidene thiobarbiturates synthesized or studied as bifunctional nanoparticle linkers. QCM, among other techniques, will assess the adherence of the bifunctional linkers to both the metal nanoparticles and metal oxides. Our group will synthesize naked silver nanoparticles and arylidene-thiobarbiturates.